[go: up one dir, main page]

FI906434A0 - IDENTIFIERING AV MAENNISKANS T-LYMPHOSYTEPITOPER AV PATOGEN FOER ATT UTVECKLA VACCINER. - Google Patents

IDENTIFIERING AV MAENNISKANS T-LYMPHOSYTEPITOPER AV PATOGEN FOER ATT UTVECKLA VACCINER.

Info

Publication number
FI906434A0
FI906434A0 FI906434A FI906434A FI906434A0 FI 906434 A0 FI906434 A0 FI 906434A0 FI 906434 A FI906434 A FI 906434A FI 906434 A FI906434 A FI 906434A FI 906434 A0 FI906434 A0 FI 906434A0
Authority
FI
Finland
Prior art keywords
vacciner
utveckla
maenniskans
lymphosytepitoper
identifiering
Prior art date
Application number
FI906434A
Other languages
Finnish (fi)
Other versions
FI906434A7 (en
Inventor
Ellis L Reinherz
Robert F Siliciano
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of FI906434A7 publication Critical patent/FI906434A7/en
Publication of FI906434A0 publication Critical patent/FI906434A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/43—Protozoan antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/45—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI906434A 1988-06-29 1989-06-22 IDENTIFIERING AV MAENNISKANS T-LYMPHOSYTEPITOPER AV PATOGEN FOER ATT UTVECKLA VACCINER. FI906434A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21307788A 1988-06-29 1988-06-29
PCT/US1989/002804 WO1990000063A1 (en) 1988-06-29 1989-06-22 Identification of human t-lymphocyte epitopes in pathogens for vaccine development

Publications (2)

Publication Number Publication Date
FI906434A7 FI906434A7 (en) 1990-12-28
FI906434A0 true FI906434A0 (en) 1990-12-28

Family

ID=22793659

Family Applications (1)

Application Number Title Priority Date Filing Date
FI906434A FI906434A0 (en) 1988-06-29 1989-06-22 IDENTIFIERING AV MAENNISKANS T-LYMPHOSYTEPITOPER AV PATOGEN FOER ATT UTVECKLA VACCINER.

Country Status (5)

Country Link
EP (1) EP0422115A4 (en)
JP (1) JPH04502144A (en)
AU (1) AU630364B2 (en)
FI (1) FI906434A0 (en)
WO (1) WO1990000063A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595881A (en) * 1994-08-09 1997-01-21 Anergen, Inc. Method for the detection of antigen presenting cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556645A (en) * 1984-06-27 1985-12-03 Union Carbide Corporation Enhanced catalyst for conversion of syngas to liquid motor fuels
JPH0334997A (en) * 1989-06-30 1991-02-14 Naochika Takahashi Lymphoid cell-activating factor, production thereof and production of virus antibody using same factor

Also Published As

Publication number Publication date
EP0422115A4 (en) 1991-07-03
EP0422115A1 (en) 1991-04-17
JPH04502144A (en) 1992-04-16
AU3963189A (en) 1990-01-23
AU630364B2 (en) 1992-10-29
WO1990000063A1 (en) 1990-01-11
FI906434A7 (en) 1990-12-28

Similar Documents

Publication Publication Date Title
FI893340L (en) FOERFARANDE FOER ATT ERHAOLLA FARMACEUTISKA SAMMANSAETTNINGAR FOER ATT HINDRA SMITTBARA KOENSSJUKDOMAR.
FI893555L (en) ANORDNING FOER ATT BILDA EN REGNBAOGE.
FI880233A0 (en) ANORDINATION FOER SKAERPNING AV KNIVAR.
FI880420A0 (en) ANORDNING FOER BESTRYKNING AV MATERIALBANA.
FI892763L (en) SPRAY-MUNSTYCKESAMMANSAETTNING FOER ATT KYLA AV EN KOLV.
FI890062A7 (en) ANORDNING FOER ATT HINDRA FRYSNING AV ARBETSMEDIET I EN ABSORPTIONSKYLAPPARAT.
FI893068L (en) FOERFARANDE FOER FRAMSTAELLNING AV HALOGENISERADE SULFONER.
FI890389A7 (en) FOERFARANDE FOER ATT FOERHOEJA HJAERNFUNKTIONEN.
FI895870A0 (en) ANORDNING FOER ATT HINDRA OTILLAOTEN MANIPULERING.
FI906434A0 (en) IDENTIFIERING AV MAENNISKANS T-LYMPHOSYTEPITOPER AV PATOGEN FOER ATT UTVECKLA VACCINER.
FI881885A0 (en) FOERFARANDE FOER ATT MAETA LAENGDGENOMSSKAERNING AV EN VAOG.
FI882290A0 (en) ANORDNING FOER ATT DAEMPA STOERNINGAR I MASSASUSPENSIONSSTROEMMAR AV PAPPERSMASKINEN.
FI884382A0 (en) REGLERINGSFOERFARANDE I INLOPPSLAODAN AV EN PAPPERSMASKIN FOER ATT BEHAERSKA SNEDVRIDNINGEN I PAPPERSBANANS FIBERORIENTERING.
FI884570A0 (en) SKYDDSHUVA FOER ATT SKYDDA VARUPAKET.
FI881886L (en) FOERFARANDE FOER ATT MAETA FRISIKTSOMRAODE.
FI882679A7 (en) ANORDNING FOER ATT UNDERLAETTA FAESTNING.
FI882793A0 (en) KOMBINERAT VERKTYG SAERSKILT FOER ATT UTFOERA SKYFFLINGS- OCH BORSTNINGSAOTGAERDER.
FI882570A0 (en) SAETT ATT FRAMSTAELLA EN TUNNA.
FI880295A0 (en) FORDONSDAECK AVSETT ATT STIFTAS.
FI882423A0 (en) ANORDNING FOER ATT UPPSLAO PLOGNINGSMAERKEN.
FI894418L (en) ANORDNING FOER ATT AOSTADSKOMMA EN GRUNDKONSTRUKTION.
FI881033A0 (en) ANORDNING FOER ATT GOERA KLAEDTORKNINGEN SNABBARE.
FI881854A0 (en) ANORDNING FOER HINDRA EN SKIDA ATT HALKA BAKAOT.
FI880447A0 (en) FOERFARANDE FOER BYGGANDE AV UNDERBYGGNAD FOER KONSTIS.
FI880191A0 (en) FOERFARANDE FOER OEKNING AV FRIKTION.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: DANA FARBER CANCER INSTITUTE